Neuland Laboratories share price hit a new high of Rs 14,500 on the BSE, surging 16% intraday and closing 12.8% higher at Rs 14,100 on expectation of strong Q2FY25 earnings. The company’s stock has more than doubled in the last four months, recording its highest-ever quarterly revenue in Q1FY25 at Rs 444.4 crore, driven by growth in the CMS business, with healthy Ebitda margins. Neuland Labs, a pharmaceutical manufacturer, is focusing on expanding its CMS business and expects business momentum to pick up from FY26 onwards, supported by a growing market for API within the CDMO sector.
Full Article
2 Artificial Intelligence (AI) Stocks to Buy and Hold for the Next 20 Years
Artificial intelligence (AI) is transforming various industries, with IDC predicting that it will add nearly $20 trillion to the global economy in the next five years. By 2045, strategic investments in AI-related stocks could yield significant returns for investors. The article highlights two specific stocks that have the potential to generate substantial profits over the next two decades. Full Article
Read more